[{"Assets_0_Q2_USD":240456000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-44306000.0,"NetIncomeLoss_1_Q2_USD":23567000.0,"NetIncomeLoss_2_Q2_USD":3563000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":69479016.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":69310791.0,"EarningsPerShareBasic_1_Q2_USD":0.34,"EarningsPerShareBasic_2_Q2_USD":0.05,"Ticker":"CHRS","CIK":"1512762","name":"COHERUS BIOSCIENCES, INC.","OfficialName":"Coherus BioSciences Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"802681020.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190805"}]